Speaker(s): 

Matthew Wright, MD, PhD, Geisinger - has nothing to disclose.

Moderator(s): 

Jessica Sevecke, PhD, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to:

• Describe recent technological advances in neuroscience that transform our ability to understand the circuit basis of psychiatric disease​
• Explain the issue of neural cell-type heterogeneity and how it affects our understanding of neural circuits​
• Discuss new research findings related to the neural circuit underpinnings of depression​
• Describe how such findings may impact future treatments of depression ​

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Jessica Sevecke-Hanrahan,PhD, Jessie Goldhirsh, MD, Dominick Agosti, LCSW, Priscilla Riley, LPC and Lauryn Eister, MSN, CRNP, PMHNP-BC have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.